Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice
N. Sato et al., Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice, J IMMUNOL, 163(10), 1999, pp. 5519-5525
We investigated the immune responses in mice lacking CCR2, CCR5, or macroph
age inflammatory protein-la (MIP-1 alpha), a ligand for CCR5, in two situat
ions: following T cell stimulation or after challenge with Leishmania donov
ani, an intracellular microbe whose control is dependent on a Th1 immune re
sponse. Mice deficient in CCR5, MIP-1 alpha, or CCR2 had reduced IFN-gamma
responses following ligation of the TCR, Reduced IFN-gamma responses follow
ing PMA and ionomycin were also observed in CD8(+) T cells of CCR5(-/-) and
CCR2(-/-) mice. During the early phases of infection, all three knockout m
ice had low Ag-specific IFN-gamma responses. However, this reduced IFN-gamm
a response was overcome during a state of persistent Ag stimulation (chroni
c infection), and was not associated with an adverse parasitologic outcome
in any of the gene-targeted mouse strains, To the contrary, during the late
phase of infection, an exaggerated Ag-specific IFN-gamma response was evid
ent in CCR5(-/-) and MIP-1 alpha(-/-) mice, and this correlated,vith an enh
anced control of parasite replication. Although granuloma formation was abn
ormal in each of the knockout mice, there was no correlation between the nu
mber or architecture of the granulomas and parasite burden. Collectively, t
hese findings indicate an important role for CCR5, MIP-1 alpha, and CCR2 in
granulomatous inflammation, and that CCR5 and MIP-1 alpha, possibly acting
through CCR5, might play a deleterious role in the outcome of chronic L, d
onovani infection, Our data also suggest that there might be cross-talk bet
ween TCR and chemokine receptor signaling pathways.